2) Patient compliance: The way by which GLP-1-RAs are taken (subcutaneously or orally), and the frequency of taking each dose, are both factors influencing patients on whether they will strictly follow the medication instructions
Two effective options you might encounter are GLP-1 receptor agonists (GLP-1s) and DPP-4 inhibitors
The active ingredient may be the same or similar, but compounded formulations have not been individually evaluated by the FDA for safety, effectiveness, or quality
Compounded GLP-1 medications: naming conventions and legal status Compounded GLP-1 medications use the generic drug name (semaglutide, tirzepatide) rather than brand names
[2] [3] The distinction between expected pharmacologic gastric slowing and pathologic gastroparesis requires careful evaluation of both incidence data and clinical presentation
Join thousands of others who have transformed their lives with our customized programs.